Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?

Int J Pharm. 2020 Aug 30:586:119581. doi: 10.1016/j.ijpharm.2020.119581. Epub 2020 Jun 27.

Abstract

Peptides are therapeutic molecules with high potential to treat a wide variety of diseases. They are large hydrophilic compounds for which absorption is limited by the intestinal epithelial border covered by mucus. This study aimed to evaluate the potential of Hydrophobic Ion Pairing combined with Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) to improve peptide transport across the intestinal border using Caco-2 cell monolayers (enterocyte-like model) and Caco-2/HT29-MTX co-cultured monolayers (mucin-secreting model). A Hydrophobic Ion Pair (HIP) was formed between Leuprolide (LEU), a model peptide, and sodium docusate. The marked increase in peptide lipophilicity enabled high encapsulation efficiencies in both NLC (84%) and SLN (85%). After co-incubation with the nanoparticles, confocal microscopy images of the cell monolayers demonstrated particles internalization and ability to cross mucus. Flow cytometry measurements confirmed that 82% of incubated SLN and 99% of NLC were internalized by Caco-2 cells. However, LEU transport across cell monolayers was not improved by the nanocarriers. Indeed, combination of particles platelet-shape and HIP low stability in the transport medium led to LEU burst release in this environment. Improvement of peptide lipidization should maintain encapsulation and enable benefit from nanocarriers enhanced intestinal transport.

Keywords: Cell models; Hydrophobic ion pair; Intestinal permeability; Nanostructured lipid carriers; Peptide; Solid lipid nanoparticles.

Publication types

  • Comparative Study

MeSH terms

  • Caco-2 Cells
  • Coculture Techniques
  • Dioctyl Sulfosuccinic Acid / chemistry
  • Drug Carriers / chemistry*
  • HT29 Cells
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Intestinal Absorption
  • Intestinal Mucosa / metabolism
  • Leuprolide / administration & dosage
  • Leuprolide / chemistry
  • Leuprolide / pharmacokinetics*
  • Lipids / chemistry*
  • Mucus / metabolism
  • Nanoparticles
  • Nanostructures*
  • Peptides / administration & dosage
  • Peptides / chemistry
  • Peptides / pharmacokinetics

Substances

  • Drug Carriers
  • Lipids
  • Peptides
  • Dioctyl Sulfosuccinic Acid
  • Leuprolide